Sign in
Taking people in United StatesNo phase

Testing a support program to help stroke patients use CPAP for sleep apnea

Tests extra CPAP support for stroke patients with sleep apnea during rehabilitation.

Key facts

Who runs it
University of Washington
Where
Downey and Seattle, United StatesSee the 2 sites
Trial code
Registry title
Stroke and CPAP Outcome Study 3 Randomized Controlled Trial
Status
Recruiting
People taking part
250 people, planned
Started
15 Jan 2025
Expected to end
May 2028
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • CPAP device
  • CPAP technical support
  • Phone follow-up for adherence feedback and self-management skills
  • myAir
  • Tailored messages
  • Written Materials
  • Motivational Enhancement Therapy (MET)
Record updated
13 August 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults who recently had a stroke, are in inpatient rehabilitation and have obstructive sleep apnea. It tests extra support for using a CPAP breathing device.

Age
18 years or older
Sex
All sexes can join
Disease stage
A brain scan shows a new stroke (blocked blood vessel or bleeding in the brain tissue) within the past 30 days.
Earlier treatment
People cannot join if they used positive airway pressure within 14 days before the stroke.

Main reasons for not taking part

  • Known pregnancy
  • Breathing machine, tracheostomy, or oxygen above 4L/min
  • Stroke caused by tumors, vascular malformations or subarachnoid hemorrhage
  • Expected inpatient rehabilitation stay under 5 nights
  • Cannot give consent in English or Spanish

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • Age 18 years or older
  • Head CT or brain MRI demonstrating an acute ischemic infarction or intraparenchymal hemorrhage within past 30 days
  • Person providing consent (patient or legally authorized representative (LAR)) able to be consented in English or Spanish

Who cannot take part

  • Use of positive airway pressure within 14 days prior to stroke
  • Active use of sedative drugs that can interfere with testing for obstructive sleep apnea (OSA) including any benzodiazepine, barbiturate, general anesthesia, or conscious sedation within the prior 48 hours of the planned portable sleep apnea study
  • Recent cranial or spinal surgery with known or possible CSF leak or pneumocephalus within past 3 months
  • History of pneumothorax, bullous emphysema or other serious co-morbid conditions which limit CPAP use
  • Stroke related to tumors, vascular malformations or subarachnoid hemorrhage
  • Co-morbid conditions that limit OSA testing or CPAP use in the judgement of the study team
  • Unable to obtain informed consent from participant or LAR in English or Spanish
  • Incarcerated
  • Known pregnancy-determined by reviewing clinical data
  • Current mechanical ventilation, tracheostomy, or supplemental oxygen use > 4L/min
  • Anticipated inpatient rehabilitation length of stay < 5 nights
  • Patients at significant risk of aspiration that could render the patient at risk of harm from use of CPAP, in the opinion of the site PI

Where in United States

  • Rancho Research InstituteDowney, United StatesContact: Jason GarciaTaking people
  • University of Washington - Harborview Medical CenterSeattle, United StatesContact: Belqeis Abatiyow, BSTaking people

About the trial

What the trial wants to find out

The SCOUTS 3 study aims to test the effectiveness of an intensive CPAP (Continuous Positive Airway Pressure) therapy support program compared to usual care in stroke patients with obstructive sleep apnea (OSA) during inpatient rehabilitation (IPR).

Read full original descriptionShow less

The study is a multicenter randomized controlled trial (RCT) involving recruitment of about 250 participants across two institutions and randomization of about 200 participants. It compares an intensive support (IS) program for CPAP use with standard support (SS) to evaluate the effectiveness of the IS intervention in increasing CPAP usage during and after stroke rehabilitation. The Intensive Support (IS) group will receive a multicomponent intensive behavioral adherence program, which includes a CPAP technical support intervention, Motivational Enhancement Therapy (MET), and a Mobile Health intervention. Outcomes measured include CPAP adherence as measured by average nightly use in minutes between randomization and 3 months and the modified Rankin Scale (mRS-9Q) to evaluate stroke recovery.

The 2 groups in the trial

  • Intensive SupportTreatment being tested

    The Intensive Support (IS) group will receive the multicomponent intensive behavioral adherence program, which includes a CPAP technical support intervention, Motivational Enhancement Therapy (MET), and a Mobile Health intervention. Participants assigned to the IS group will also receive the 3 basic supportive treatments, including OSA and CPAP education, respiratory therapy and nursing support during inpatient rehabilitation, and referral to a DME company after inpatient rehabilitation discharge if needed.

    Treatment: CPAP device, CPAP technical support, Phone follow-up for adherence feedback and self-management skills, myAir, Tailored messages, Written Materials, and Motivational Enhancement Therapy (MET)

  • Standard SupportExisting treatment, for comparison

    Participants assigned to the control group will receive only the 3 basic supportive treatments, including OSA and CPAP education, respiratory therapy and nursing support during inpatient rehabilitation, and referral to a DME company after study completion if needed. CPAP will be set up by the respiratory therapist (or similar personnel) on the inpatient rehabilitation (IPR) unit with standard mask fitting and troubleshooting, if available. Assistance with mask placement will be provided by IPR nurses and respiratory therapy, as needed. The control interventions mimic usual care, which typically entails a setup by respiratory therapy and support for CPAP placement and device maintenance by IPR nurses.

    Treatment: CPAP device

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Optimizing Adherence to the Treatment of Sleep Apnea Among Patients With Stroke Undergoing Inpatient Rehabilitation
Plain-language title
Testing a support program to help stroke patients use CPAP for sleep apneaGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
13 August 2026